JP Morgan's Pharma Picks and Growth in India's CDMO Sector Highlighted
JP Morgan highlights four pharmaceutical stocks—Torrent Pharma, Cipla, Divi's Laboratories, and Anthem Biosciences—with up to 25% upside potential, emphasizing Torrent Pharma's growth driven by JB Pharma integration and specialty product launches. Separately, India's Contract Development and Manufacturing Organization (CDMO) sector is gaining prominence globally, with companies like Laurus Labs expanding capabilities in advanced pharmaceutical manufacturing and research services, supported by investments in capacity and technology to meet rising multinational demand.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (72/100). Lens Score 32/100.
Outlets measured: thefinancialexpress, thefinancialexpress. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (70–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
thefinancialexpress broke this story on 7 Oct, 08:35 am. Other outlets followed.
- 1